fullerene c60 has been researched along with morphine in 1 studies
| Studies (fullerene c60) | Trials (fullerene c60) | Recent Studies (post-2010) (fullerene c60) | Studies (morphine) | Trials (morphine) | Recent Studies (post-2010) (morphine) |
|---|---|---|---|---|---|
| 3,806 | 5 | 2,170 | 44,270 | 5,200 | 8,695 |
| Protein | Taxonomy | fullerene c60 (IC50) | morphine (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.2939 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.2278 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.0828 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0385 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0545 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.122 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.1199 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.9308 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.655 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.3305 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.202 | |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, S; Kobayashi, S; Matsubayashi, K; Mori, T; Namiki, M; Sawaguchi, T; Suzuki, T | 1 |
1 other study(ies) available for fullerene c60 and morphine
| Article | Year |
|---|---|
Involvement of free radicals followed by the activation of phospholipase A2 in the mechanism that underlies the combined effects of methamphetamine and morphine on subacute toxicity or lethality in mice: comparison of the therapeutic potential of fulleren
Topics: Animals; Body Temperature; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Enzyme Activation; Enzyme Inhibitors; Free Radical Scavengers; Free Radicals; Fullerenes; Heart; Hypothermia, Induced; Illicit Drugs; Kidney; Liver; Male; Methamphetamine; Mice; Mice, Inbred BALB C; Morphine; Myocardium; Phospholipases A; Phospholipases A2; Quinacrine | 2007 |